Back to Search
Start Over
Daridorexant Receives Approval for Insomnia Treatment: Daridorexant demonstrated significant reduction in daytime sleepiness among other measures
- Source :
- Drug Topics. June, 2022, Vol. 166 Issue 6, p37, 1 p.
- Publication Year :
- 2022
-
Abstract
- On January 7, 2022, the FDA approved daridorexant (Quviviq) for the treatment of adults with insomnia.1 The approval was based on findings from a phase 3 clinical trial program in [...]
Details
- Language :
- English
- ISSN :
- 00126616
- Volume :
- 166
- Issue :
- 6
- Database :
- Gale General OneFile
- Journal :
- Drug Topics
- Publication Type :
- Periodical
- Accession number :
- edsgcl.708385905